25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

P&K Skin Research Center Co. Ltd
Buy, Hold or Sell?

Let's analyze P&K Skin Research Center Co. Ltd together

I guess you are interested in P&K Skin Research Center Co. Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of P&K Skin Research Center Co. Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about P&K Skin Research Center Co. Ltd

I send you an email if I find something interesting about P&K Skin Research Center Co. Ltd.

1. Quick Overview

1.1. Quick analysis of P&K Skin Research Center Co. Ltd (30 sec.)










1.2. What can you expect buying and holding a share of P&K Skin Research Center Co. Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
21.1%

What is your share worth?

Current worth
₩2,525.03
Expected worth in 1 year
₩2,656.93
How sure are you?
94.7%

+ What do you gain per year?

Total Gains per Share
₩131.90
Return On Investment
6.1%

For what price can you sell your share?

Current Price per Share
₩2,145.00
Expected price per share
₩1,980 - ₩2,325
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of P&K Skin Research Center Co. Ltd (5 min.)




Live pricePrice per Share (EOD)
₩2,145.00

2.2. Growth of P&K Skin Research Center Co. Ltd (5 min.)




Is P&K Skin Research Center Co. Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$51.4m$49.3m$1.9m3.9%

How much money is P&K Skin Research Center Co. Ltd making?

Current yearPrevious yearGrowGrow %
Making money$937.2k$1m-$126.7k-13.5%
Net Profit Margin32.2%34.6%--

How much money comes from the company's main activities?

2.3. Financial Health of P&K Skin Research Center Co. Ltd (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of P&K Skin Research Center Co. Ltd?

Welcome investor! P&K Skin Research Center Co. Ltd's management wants to use your money to grow the business. In return you get a share of P&K Skin Research Center Co. Ltd.

First you should know what it really means to hold a share of P&K Skin Research Center Co. Ltd. And how you can make/lose money.

Speculation

The Price per Share of P&K Skin Research Center Co. Ltd is ₩2,145. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of P&K Skin Research Center Co. Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in P&K Skin Research Center Co. Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩2,525.03. Based on the TTM, the Book Value Change Per Share is ₩32.97 per quarter. Based on the YOY, the Book Value Change Per Share is ₩48.61 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of P&K Skin Research Center Co. Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.030.0%0.030.0%0.040.0%0.040.0%0.040.0%
Usd Book Value Change Per Share0.010.0%0.020.0%0.030.0%0.090.0%0.090.0%
Usd Dividend Per Share0.000.0%0.000.0%0.020.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.010.0%0.020.0%0.050.0%0.100.0%0.100.0%
Usd Price Per Share2.35-2.00-2.27-6.97-6.97-
Price to Earnings Ratio22.58-17.34-24.30-50.32-50.32-
Price-to-Total Gains Ratio231.86-131.12-79.85-308.92-308.92-
Price to Book Ratio1.33-1.14-1.38-4.80-4.80-
Price-to-Total Gains Ratio231.86-131.12-79.85-308.92-308.92-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.5015
Number of shares666
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.020.09
Usd Total Gains Per Share0.020.10
Gains per Quarter (666 shares)15.3764.87
Gains per Year (666 shares)61.49259.47
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10615112248249
2012311223496508
3018417335743767
40246234479911026
503072955812391285
603693567014871544
704304178217351803
804924789319832062
9055353910522302321
10061560011624782580

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%18.00.01.094.7%18.00.01.094.7%18.00.01.094.7%
Dividend per Share0.00.04.00.0%4.00.08.033.3%4.00.015.021.1%4.00.015.021.1%4.00.015.021.1%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%18.00.01.094.7%18.00.01.094.7%18.00.01.094.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of P&K Skin Research Center Co. Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--14.47032.974-56%48.614-70%132.896-89%132.896-89%
Book Value Per Share--2525.0332489.160+1%2351.310+7%1980.565+27%1980.565+27%
Current Ratio--19.17819.173+0%17.904+7%16.018+20%16.018+20%
Debt To Asset Ratio--0.0440.044-1%0.051-15%0.057-23%0.057-23%
Debt To Equity Ratio--0.0450.046-1%0.054-15%0.061-25%0.061-25%
Dividend Per Share----0%22.142-100%6.246-100%6.246-100%
Eps--37.15345.379-18%50.650-27%52.992-30%52.992-30%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap61951461000.000-58%97637075800.00083997292535.000+16%97234279200.000+0%292461474838.947-67%292461474838.947-67%
Net Profit Margin--0.2830.322-12%0.346-18%0.382-26%0.382-26%
Operating Margin----0%-0%0.078-100%0.078-100%
Operating Ratio--1.0651.303-18%0.875+22%0.651+64%0.651+64%
Pb Ratio0.849-56%1.3291.145+16%1.378-4%4.802-72%4.802-72%
Pe Ratio14.433-56%22.57517.342+30%24.303-7%50.315-55%50.315-55%
Price Per Share2145.000-56%3355.0002851.250+18%3240.000+4%9953.421-66%9953.421-66%
Price To Free Cash Flow Ratio----31.2070%16.749-100%12.383-100%12.383-100%
Price To Total Gains Ratio148.237-56%231.858131.119+77%79.846+190%308.919-25%308.919-25%
Quick Ratio---11.255-100%33.724-100%23.018-100%23.018-100%
Return On Assets--0.0140.017-19%0.021-31%0.026-45%0.026-45%
Return On Equity--0.0150.018-19%0.022-32%0.027-46%0.027-46%
Total Gains Per Share--14.47032.974-56%70.756-80%139.142-90%139.142-90%
Usd Book Value--51438380.00051383163.139+0%49394928.167+4%40948037.189+26%40948037.189+26%
Usd Book Value Change Per Share--0.0100.023-56%0.034-70%0.093-89%0.093-89%
Usd Book Value Per Share--1.7681.742+1%1.646+7%1.386+27%1.386+27%
Usd Dividend Per Share----0%0.015-100%0.004-100%0.004-100%
Usd Eps--0.0260.032-18%0.035-27%0.037-30%0.037-30%
Usd Free Cash Flow---684261.382-100%1445575.572-100%1302835.629-100%1302835.629-100%
Usd Market Cap43366022.700-58%68345953.06058798104.775+16%68063995.440+0%204723032.387-67%204723032.387-67%
Usd Price Per Share1.502-56%2.3491.996+18%2.268+4%6.967-66%6.967-66%
Usd Profit--756866.600937283.841-19%1064032.555-29%1138310.303-34%1138310.303-34%
Usd Revenue--2671742.5002849495.406-6%2905270.877-8%2939397.513-9%2939397.513-9%
Usd Total Gains Per Share--0.0100.023-56%0.050-80%0.097-90%0.097-90%
 EOD+3 -4MRQTTM+11 -16YOY+13 -175Y+10 -2110Y+10 -21

3.3 Fundamental Score

Let's check the fundamental score of P&K Skin Research Center Co. Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1514.433
Price to Book Ratio (EOD)Between0-10.849
Net Profit Margin (MRQ)Greater than00.283
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than119.178
Debt to Asset Ratio (MRQ)Less than10.044
Debt to Equity Ratio (MRQ)Less than10.045
Return on Equity (MRQ)Greater than0.150.015
Return on Assets (MRQ)Greater than0.050.014
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of P&K Skin Research Center Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.051
Ma 20Greater thanMa 502,262.250
Ma 50Greater thanMa 1002,445.800
Ma 100Greater thanMa 2002,620.100
OpenGreater thanClose2,120.000
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About P&K Skin Research Center Co. Ltd

P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vitro clinical tests. It also manufactures and sells raw pharmaceutical and cosmetic materials, and raw materials for health foods. The company was founded in 2010 and is based in Seoul, South Korea. P&K Skin Research Center Co., Ltd. operates as a subsidiary of Daebongls.Co.,Ltd.

Fundamental data was last updated by Penke on 2024-11-11 09:01:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit P&K Skin Research Center Co. Ltd earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare P&K Skin Research Center Co. Ltd to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 28.3% means that ₩0.28 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of P&K Skin Research Center Co. Ltd:

  • The MRQ is 28.3%. The company is making a huge profit. +2
  • The TTM is 32.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ28.3%TTM32.2%-3.8%
TTM32.2%YOY34.6%-2.4%
TTM32.2%5Y38.2%-6.0%
5Y38.2%10Y38.2%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ28.3%-5.6%+33.9%
TTM32.2%-8.8%+41.0%
YOY34.6%-0.8%+35.4%
5Y38.2%-1.9%+40.1%
10Y38.2%-0.3%+38.5%
4.3.1.2. Return on Assets

Shows how efficient P&K Skin Research Center Co. Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare P&K Skin Research Center Co. Ltd to the Diagnostics & Research industry mean.
  • 1.4% Return on Assets means that P&K Skin Research Center Co. Ltd generated ₩0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of P&K Skin Research Center Co. Ltd:

  • The MRQ is 1.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.7%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.4%TTM1.7%-0.3%
TTM1.7%YOY2.1%-0.3%
TTM1.7%5Y2.6%-0.8%
5Y2.6%10Y2.6%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4%-1.2%+2.6%
TTM1.7%-2.1%+3.8%
YOY2.1%-0.9%+3.0%
5Y2.6%-0.1%+2.7%
10Y2.6%-0.5%+3.1%
4.3.1.3. Return on Equity

Shows how efficient P&K Skin Research Center Co. Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare P&K Skin Research Center Co. Ltd to the Diagnostics & Research industry mean.
  • 1.5% Return on Equity means P&K Skin Research Center Co. Ltd generated ₩0.01 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of P&K Skin Research Center Co. Ltd:

  • The MRQ is 1.5%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.5%TTM1.8%-0.4%
TTM1.8%YOY2.2%-0.3%
TTM1.8%5Y2.7%-0.9%
5Y2.7%10Y2.7%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5%-0.4%+1.9%
TTM1.8%-1.7%+3.5%
YOY2.2%0.3%+1.9%
5Y2.7%-0.9%+3.6%
10Y2.7%-0.9%+3.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of P&K Skin Research Center Co. Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient P&K Skin Research Center Co. Ltd is operating .

  • Measures how much profit P&K Skin Research Center Co. Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare P&K Skin Research Center Co. Ltd to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of P&K Skin Research Center Co. Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y7.8%-7.8%
5Y7.8%10Y7.8%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--9.6%+9.6%
TTM--12.4%+12.4%
YOY-2.6%-2.6%
5Y7.8%1.4%+6.4%
10Y7.8%4.1%+3.7%
4.3.2.2. Operating Ratio

Measures how efficient P&K Skin Research Center Co. Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.07 means that the operating costs are ₩1.07 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of P&K Skin Research Center Co. Ltd:

  • The MRQ is 1.065. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.303. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.065TTM1.303-0.237
TTM1.303YOY0.875+0.427
TTM1.3035Y0.651+0.651
5Y0.65110Y0.6510.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0651.311-0.246
TTM1.3031.294+0.009
YOY0.8751.266-0.391
5Y0.6511.208-0.557
10Y0.6511.191-0.540
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of P&K Skin Research Center Co. Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if P&K Skin Research Center Co. Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 19.18 means the company has ₩19.18 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of P&K Skin Research Center Co. Ltd:

  • The MRQ is 19.178. The company is very able to pay all its short-term debts. +2
  • The TTM is 19.173. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ19.178TTM19.173+0.004
TTM19.173YOY17.904+1.269
TTM19.1735Y16.018+3.155
5Y16.01810Y16.0180.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ19.1782.028+17.150
TTM19.1732.113+17.060
YOY17.9042.555+15.349
5Y16.0182.668+13.350
10Y16.0183.230+12.788
4.4.3.2. Quick Ratio

Measures if P&K Skin Research Center Co. Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare P&K Skin Research Center Co. Ltd to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of P&K Skin Research Center Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM11.255-11.255
TTM11.255YOY33.724-22.469
TTM11.2555Y23.018-11.763
5Y23.01810Y23.0180.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.206-1.206
TTM11.2551.241+10.014
YOY33.7241.685+32.039
5Y23.0182.100+20.918
10Y23.0182.428+20.590
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of P&K Skin Research Center Co. Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of P&K Skin Research Center Co. Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare P&K Skin Research Center Co. Ltd to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.04 means that P&K Skin Research Center Co. Ltd assets are financed with 4.4% credit (debt) and the remaining percentage (100% - 4.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of P&K Skin Research Center Co. Ltd:

  • The MRQ is 0.044. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.044. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.044TTM0.0440.000
TTM0.044YOY0.051-0.007
TTM0.0445Y0.057-0.013
5Y0.05710Y0.0570.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0440.437-0.393
TTM0.0440.440-0.396
YOY0.0510.359-0.308
5Y0.0570.428-0.371
10Y0.0570.450-0.393
4.5.4.2. Debt to Equity Ratio

Measures if P&K Skin Research Center Co. Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare P&K Skin Research Center Co. Ltd to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 4.5% means that company has ₩0.05 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of P&K Skin Research Center Co. Ltd:

  • The MRQ is 0.045. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.046. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.045TTM0.0460.000
TTM0.046YOY0.054-0.008
TTM0.0465Y0.061-0.015
5Y0.06110Y0.0610.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0450.640-0.595
TTM0.0460.686-0.640
YOY0.0540.502-0.448
5Y0.0610.666-0.605
10Y0.0610.712-0.651
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings P&K Skin Research Center Co. Ltd generates.

  • Above 15 is considered overpriced but always compare P&K Skin Research Center Co. Ltd to the Diagnostics & Research industry mean.
  • A PE ratio of 22.58 means the investor is paying ₩22.58 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of P&K Skin Research Center Co. Ltd:

  • The EOD is 14.433. Based on the earnings, the company is underpriced. +1
  • The MRQ is 22.575. Based on the earnings, the company is fair priced.
  • The TTM is 17.342. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD14.433MRQ22.575-8.142
MRQ22.575TTM17.342+5.233
TTM17.342YOY24.303-6.961
TTM17.3425Y50.315-32.973
5Y50.31510Y50.3150.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD14.433-0.356+14.789
MRQ22.575-0.693+23.268
TTM17.342-0.881+18.223
YOY24.303-0.145+24.448
5Y50.3151.937+48.378
10Y50.3153.727+46.588
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of P&K Skin Research Center Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-31.207+31.207
TTM-31.207YOY16.749-47.956
TTM-31.2075Y12.383-43.590
5Y12.38310Y12.3830.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--1.088+1.088
TTM-31.207-1.123-30.084
YOY16.749-2.356+19.105
5Y12.383-2.367+14.750
10Y12.383-2.248+14.631
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of P&K Skin Research Center Co. Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 1.33 means the investor is paying ₩1.33 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of P&K Skin Research Center Co. Ltd:

  • The EOD is 0.849. Based on the equity, the company is cheap. +2
  • The MRQ is 1.329. Based on the equity, the company is underpriced. +1
  • The TTM is 1.145. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.849MRQ1.329-0.479
MRQ1.329TTM1.145+0.184
TTM1.145YOY1.378-0.233
TTM1.1455Y4.802-3.657
5Y4.80210Y4.8020.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD0.8492.279-1.430
MRQ1.3292.309-0.980
TTM1.1452.317-1.172
YOY1.3782.384-1.006
5Y4.8023.753+1.049
10Y4.8024.539+0.263
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets76,826,840
Total Liabilities3,343,440
Total Stockholder Equity73,513,308
 As reported
Total Liabilities 3,343,440
Total Stockholder Equity+ 73,513,308
Total Assets = 76,826,840

Assets

Total Assets76,826,840
Total Current Assets54,509,839
Long-term Assets22,317,001
Total Current Assets
Total Current Assets  (as reported)54,509,839
Total Current Assets  (calculated)0
+/- 54,509,839
Long-term Assets
Long-term Assets  (as reported)22,317,001
Long-term Assets  (calculated)0
+/- 22,317,001

Liabilities & Shareholders' Equity

Total Current Liabilities2,842,381
Long-term Liabilities501,060
Total Stockholder Equity73,513,308
Total Current Liabilities
Total Current Liabilities  (as reported)2,842,381
Total Current Liabilities  (calculated)0
+/- 2,842,381
Long-term Liabilities
Long-term Liabilities  (as reported)501,060
Long-term Liabilities  (calculated)0
+/- 501,060
Total Stockholder Equity
Total Stockholder Equity (as reported)73,513,308
Total Stockholder Equity (calculated)0
+/- 73,513,308
Other
Common Stock Shares Outstanding 29,102
Net Invested Capital 73,513,308
Net Working Capital 51,667,458



6.2. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
> Total Assets 
0
29,878,360
31,600,914
57,801,403
59,891,743
61,650,863
63,499,305
64,310,405
67,093,588
68,628,763
68,568,447
71,837,471
74,539,350
75,676,028
75,393,724
75,935,129
77,407,166
76,879,994
76,826,840
76,826,84076,879,99477,407,16675,935,12975,393,72475,676,02874,539,35071,837,47168,568,44768,628,76367,093,58864,310,40563,499,30561,650,86359,891,74357,801,40331,600,91429,878,3600
   > Total Current Assets 
24,324,941
25,828,581
27,525,011
48,911,893
51,251,517
44,049,302
49,562,372
44,681,637
44,017,895
39,501,034
37,532,748
52,745,462
60,359,088
50,049,946
52,820,803
52,714,161
51,078,786
54,196,994
54,509,839
54,509,83954,196,99451,078,78652,714,16152,820,80350,049,94660,359,08852,745,46237,532,74839,501,03444,017,89544,681,63749,562,37244,049,30251,251,51748,911,89327,525,01125,828,58124,324,941
       Cash And Cash Equivalents 
0
9,858,130
14,178,713
2,592,180
3,889,922
1,831,570
357
182
194
1,313
2,107
332
839
970
578
5,424,382
9,797,385
8,058,352
0
08,058,3529,797,3855,424,3825789708393322,1071,3131941823571,831,5703,889,9222,592,18014,178,7139,858,1300
       Short-term Investments 
0
0
0
44,425,826
45,832,837
40,030,045
44,536,490
37,145,241
40,737,746
34,614,565
33,322,840
48,478,383
52,480,980
45,440,416
47,214,881
43,958,709
34,890,333
39,618,474
0
039,618,47434,890,33343,958,70947,214,88145,440,41652,480,98048,478,38333,322,84034,614,56540,737,74637,145,24144,536,49040,030,04545,832,83744,425,826000
       Net Receivables 
1,454,612
1,432,757
1,118,336
1,570,117
1,191,225
1,625,641
1,000,328
1,214,421
1,397,805
1,144,057
1,187,495
1,553,809
2,407,781
1,616,411
1,542,620
1,530,735
1,670,297
1,544,989
0
01,544,9891,670,2971,530,7351,542,6201,616,4112,407,7811,553,8091,187,4951,144,0571,397,8051,214,4211,000,3281,625,6411,191,2251,570,1171,118,3361,432,7571,454,612
       Other Current Assets 
18,461
0
0
155,284
81,429
236,993
0
0
0
0
0
0
0
0
0
0
-1
0
0
00-10000000000236,99381,429155,2840018,461
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
14,180,262
25,626,082
22,572,921
23,220,968
26,328,380
22,683,001
22,317,001
22,317,00122,683,00126,328,38023,220,96822,572,92125,626,08214,180,262000000000000
       Property Plant Equipment 
2,331,318
2,812,164
2,835,552
2,711,760
2,530,988
4,405,078
4,638,692
4,625,004
4,617,851
4,503,085
4,657,250
4,737,758
4,571,005
4,779,841
4,941,200
4,696,411
4,638,962
4,236,474
0
04,236,4744,638,9624,696,4114,941,2004,779,8414,571,0054,737,7584,657,2504,503,0854,617,8514,625,0044,638,6924,405,0782,530,9882,711,7602,835,5522,812,1642,331,318
       Intangible Assets 
0
0
0
0
0
0
39,000
39,000
39,000
39,000
165,008
165,008
165,008
196,608
198,346
198,346
198,346
198,346
0
0198,346198,346198,346198,346196,608165,008165,008165,00839,00039,00039,00039,000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,551,729
0
1,706,726
0
0
0
0001,706,72601,551,7290000000000000
> Total Liabilities 
0
3,421,650
3,094,312
3,209,373
4,265,295
4,034,219
3,706,984
3,185,986
4,026,685
5,048,965
3,358,405
3,588,057
3,732,286
4,295,175
3,574,323
3,102,211
3,167,701
3,817,701
3,343,440
3,343,4403,817,7013,167,7013,102,2113,574,3234,295,1753,732,2863,588,0573,358,4055,048,9654,026,6853,185,9863,706,9844,034,2194,265,2953,209,3733,094,3123,421,6500
   > Total Current Liabilities 
2,646,438
2,608,999
2,329,613
2,474,171
3,564,369
3,010,847
2,716,694
2,212,471
3,117,535
4,215,355
2,603,697
2,882,067
3,084,884
3,444,747
2,748,279
2,479,029
2,589,924
3,278,804
2,842,381
2,842,3813,278,8042,589,9242,479,0292,748,2793,444,7473,084,8842,882,0672,603,6974,215,3553,117,5352,212,4712,716,6943,010,8473,564,3692,474,1712,329,6132,608,9992,646,438
       Other Current Liabilities 
1,748,021
0
0
1,780,792
2,357,591
1,999,107
0
0
0
0
0
0
0
1
0
0
-1
0
0
00-100100000001,999,1072,357,5911,780,792001,748,021
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
647,402
728,616
731,832
623,182
577,777
538,898
501,060
501,060538,898577,777623,182731,832728,616647,402000000000000
       Long term Debt Total 
0
762,606
709,418
674,387
621,885
941,615
834,223
801,518
727,942
645,472
562,442
478,851
409,197
464,908
467,655
0
0
0
0
0000467,655464,908409,197478,851562,442645,472727,942801,518834,223941,615621,885674,387709,418762,6060
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
741,005
830,398
857,651
758,962
668,235
568,356
0
0568,356668,235758,962857,651830,398741,005000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
0
0
0
000-1000000000000000
> Total Stockholder Equity
0
26,456,709
28,506,602
54,592,030
55,626,448
57,616,644
59,792,321
61,124,419
63,066,903
63,579,798
65,210,042
68,249,414
70,807,064
71,380,853
71,819,401
72,765,827
74,203,218
73,061,134
73,513,308
73,513,30873,061,13474,203,21872,765,82771,819,40171,380,85370,807,06468,249,41465,210,04263,579,79863,066,90361,124,41959,792,32157,616,64455,626,44854,592,03028,506,60226,456,7090
   Common Stock
650,240
650,240
3,054,000
3,751,322
3,751,322
3,751,322
3,751,322
3,751,322
3,751,322
3,751,322
3,751,322
15,005,288
15,005,288
15,005,288
15,005,288
0
0
0
0
000015,005,28815,005,28815,005,28815,005,2883,751,3223,751,3223,751,3223,751,3223,751,3223,751,3223,751,3223,751,3223,054,000650,240650,240
   Retained Earnings Total Equity0000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000
   Capital Surplus 
0
1,733,134
-683,521
24,423,000
24,423,000
24,423,000
24,423,000
24,423,000
24,423,000
24,423,000
24,423,000
13,094,711
13,094,711
13,094,711
13,094,711
0
0
0
0
000013,094,71113,094,71113,094,71113,094,71124,423,00024,423,00024,423,00024,423,00024,423,00024,423,00024,423,00024,423,000-683,5211,733,1340
   Treasury Stock0000000000-1,306,704-1,380,40000-1,380,4000000
   Other Stockholders Equity 
0
0
0
-1,380,400
0
0
-1,363,446
0
23,404
23,404
49,607
227,992
227,992
227,992
227,992
0
0
0
0
0000227,992227,992227,992227,99249,60723,40423,4040-1,363,44600-1,380,400000



6.3. Balance Sheets

Currency in KRW. All numbers in thousands.




6.4. Cash Flows

Currency in KRW. All numbers in thousands.




6.5. Income Statements

Currency in KRW. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue14,842,604
Cost of Revenue-7,643,590
Gross Profit7,199,0147,199,014
 
Operating Income (+$)
Gross Profit7,199,014
Operating Expense-13,463,710
Operating Income1,378,894-6,264,697
 
Operating Expense (+$)
Research Development1,356,669
Selling General Administrative788,163
Selling And Marketing Expenses0
Operating Expense13,463,7102,144,832
 
Net Interest Income (+$)
Interest Income3,639,092
Interest Expense-32,768
Other Finance Cost-32,124
Net Interest Income3,574,201
 
Pretax Income (+$)
Operating Income1,378,894
Net Interest Income3,574,201
Other Non-Operating Income Expenses0
Income Before Tax (EBT)5,356,9201,378,894
EBIT - interestExpense = -32,768
4,813,139
4,845,907
Interest Expense32,768
Earnings Before Interest and Taxes (EBIT)05,389,688
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax5,356,920
Tax Provision-656,535
Net Income From Continuing Ops4,700,3854,700,385
Net Income4,813,139
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-3,574,201
 

Technical Analysis of P&K Skin Research Center Co. Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of P&K Skin Research Center Co. Ltd. The general trend of P&K Skin Research Center Co. Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine P&K Skin Research Center Co. Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of P&K Skin Research Center Co. Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 2,155 < 2,193 < 2,325.

The bearish price targets are: 1,980.

Tweet this
P&K Skin Research Center Co. Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of P&K Skin Research Center Co. Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

P&K Skin Research Center Co. Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of P&K Skin Research Center Co. Ltd. The current macd is -107.95400361.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the P&K Skin Research Center Co. Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for P&K Skin Research Center Co. Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the P&K Skin Research Center Co. Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
P&K Skin Research Center Co. Ltd Daily Moving Average Convergence/Divergence (MACD) ChartP&K Skin Research Center Co. Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of P&K Skin Research Center Co. Ltd. The current adx is 33.46.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell P&K Skin Research Center Co. Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
P&K Skin Research Center Co. Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of P&K Skin Research Center Co. Ltd. The current sar is 1,984.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
P&K Skin Research Center Co. Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of P&K Skin Research Center Co. Ltd. The current rsi is 36.05. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
P&K Skin Research Center Co. Ltd Daily Relative Strength Index (RSI) ChartP&K Skin Research Center Co. Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of P&K Skin Research Center Co. Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the P&K Skin Research Center Co. Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
P&K Skin Research Center Co. Ltd Daily Stochastic Oscillator ChartP&K Skin Research Center Co. Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of P&K Skin Research Center Co. Ltd. The current cci is -56.16664652.

P&K Skin Research Center Co. Ltd Daily Commodity Channel Index (CCI) ChartP&K Skin Research Center Co. Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of P&K Skin Research Center Co. Ltd. The current cmo is -22.20003347.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
P&K Skin Research Center Co. Ltd Daily Chande Momentum Oscillator (CMO) ChartP&K Skin Research Center Co. Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of P&K Skin Research Center Co. Ltd. The current willr is -65.26315789.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that P&K Skin Research Center Co. Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
P&K Skin Research Center Co. Ltd Daily Williams %R ChartP&K Skin Research Center Co. Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of P&K Skin Research Center Co. Ltd.

P&K Skin Research Center Co. Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of P&K Skin Research Center Co. Ltd. The current atr is 97.94.

P&K Skin Research Center Co. Ltd Daily Average True Range (ATR) ChartP&K Skin Research Center Co. Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of P&K Skin Research Center Co. Ltd. The current obv is 115,580,010.

P&K Skin Research Center Co. Ltd Daily On-Balance Volume (OBV) ChartP&K Skin Research Center Co. Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of P&K Skin Research Center Co. Ltd. The current mfi is 36.43.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
P&K Skin Research Center Co. Ltd Daily Money Flow Index (MFI) ChartP&K Skin Research Center Co. Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for P&K Skin Research Center Co. Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-16MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

P&K Skin Research Center Co. Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of P&K Skin Research Center Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.051
Ma 20Greater thanMa 502,262.250
Ma 50Greater thanMa 1002,445.800
Ma 100Greater thanMa 2002,620.100
OpenGreater thanClose2,120.000
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of P&K Skin Research Center Co. Ltd with someone you think should read this too:
  • Are you bullish or bearish on P&K Skin Research Center Co. Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about P&K Skin Research Center Co. Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about P&K Skin Research Center Co. Ltd

I send you an email if I find something interesting about P&K Skin Research Center Co. Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about P&K Skin Research Center Co. Ltd.

Receive notifications about P&K Skin Research Center Co. Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.